Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma
- PMID: 24445148
- DOI: 10.1016/j.ejca.2013.12.021
Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma
Abstract
Background: Single cycle carboplatin, dosed by glomerular filtration rate (GFR), is standard adjuvant therapy for stage 1 seminoma. Accurate measurement of GFR is essential for correct dosing. Isotopic methods remain the gold standard for the determination of GFR. Formulae to estimate GFR have improved the assessment of renal function in non-oncological settings. We assessed the utility of these formulae for carboplatin dosing.
Methods: We studied consecutive subjects receiving adjuvant carboplatin for stage 1 seminoma at our institution between 2007 and 2012. Subjects underwent 51Cr-ethylene diamine tetra-acetic acid (EDTA) measurement of GFR with carboplatin dose calculated using the Calvert formula. Theoretical carboplatin doses were calculated from estimated GFR using Chronic Kidney Disease-Epidemiology (CKD-EPI), Management of Diet in Renal Disease (MDRD) and Cockcroft-Gault (CG) formulae with additional correction for actual body surface area (BSA). Carboplatin doses calculated by formulae were compared with dose calculated by isotopic GFR; a difference <10% was considered acceptable.
Results: 115 patients were identified. Mean isotopic GFR was 96.9 ml/min/1.73 m(2). CG and CKD-EPI tended to overestimate GFR whereas MDRD tended to underestimate GFR. The CKD-EPI formula had greatest accuracy. The CKD-EPI formula, corrected for actual BSA, performed best; 45.9% of patients received within 10% of correct carboplatin dose. Patients predicted as underdosed (13.5%) by CKD-EPI were more likely to be obese (p=0.013); there were no predictors of the 40.5% receiving an excess dose.
Conclusions: Our data support further evaluation of the CKD-EPI formula in this patient population but clinically significant variances in carboplatin dosing occur using non-isotopic methods of GFR estimation. Isotopic determination of GFR should remain the recommended standard for carboplatin dosing when accuracy is essential.
Keywords: Carboplatin; Dosing; Formula; Glomerular filtration rate; Seminoma.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Comment in
-
Response to: 'Letter to the editor, European Journal of Cancer', commenting on 'Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma'.Eur J Cancer. 2014 Aug;50(12):2178-9. doi: 10.1016/j.ejca.2014.04.027. Epub 2014 May 28. Eur J Cancer. 2014. PMID: 24878064 No abstract available.
-
Measurement or estimation of glomerular filtration rate in seminoma patients: quite another cup of tea.Eur J Cancer. 2014 Aug;50(12):2176-7. doi: 10.1016/j.ejca.2014.04.028. Epub 2014 Jun 7. Eur J Cancer. 2014. PMID: 24915777 No abstract available.
Similar articles
-
Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.Ann Oncol. 2014 Aug;25(8):1591-7. doi: 10.1093/annonc/mdu129. Epub 2014 Mar 25. Ann Oncol. 2014. PMID: 24669017
-
Inaccuracies in estimated glomerular filtration rate in one Australian renal centre.Nephrology (Carlton). 2011 Jul;16(5):486-94. doi: 10.1111/j.1440-1797.2011.01453.x. Nephrology (Carlton). 2011. PMID: 21352419
-
Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.Cancer Chemother Pharmacol. 1998;42(4):307-12. doi: 10.1007/s002800050822. Cancer Chemother Pharmacol. 1998. PMID: 9744776 Clinical Trial.
-
Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review.J Oncol Pharm Pract. 2019 Oct;25(7):1651-1657. doi: 10.1177/1078155218805136. Epub 2018 Oct 18. J Oncol Pharm Pract. 2019. PMID: 30336729 Review.
-
Accurate determination of glomerular filtration rate in adults for carboplatin dosing: Moving beyond Cockcroft and Gault.J Oncol Pharm Pract. 2021 Mar;27(2):368-375. doi: 10.1177/1078155220978446. Epub 2020 Dec 9. J Oncol Pharm Pract. 2021. PMID: 33297846 Review.
Cited by
-
Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I.ESMO Open. 2018 Mar 8;3(3):e000320. doi: 10.1136/esmoopen-2018-000320. eCollection 2018. ESMO Open. 2018. PMID: 29531843 Free PMC article.
-
Guidelines for treatment of renal injury during cancer chemotherapy 2016.Clin Exp Nephrol. 2018 Feb;22(1):210-244. doi: 10.1007/s10157-017-1448-z. Clin Exp Nephrol. 2018. PMID: 28856465 Free PMC article. Review. No abstract available.
-
The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomes.Nephrol Dial Transplant. 2023 May 4;38(5):1071-1079. doi: 10.1093/ndt/gfac011. Nephrol Dial Transplant. 2023. PMID: 35090037 Free PMC article. Review.
-
Assessment of GFR in Patients with Cancer: A Statement from the American Society of Onco-Nephrology.Clin J Am Soc Nephrol. 2024 Aug 1;19(8):1061-1072. doi: 10.2215/CJN.0000000000000508. Epub 2024 Jun 7. Clin J Am Soc Nephrol. 2024. PMID: 38848131 Free PMC article.
-
Discrepancies between the Cockcroft-Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment Strategies.Clin Pharmacokinet. 2017 Feb;56(2):193-205. doi: 10.1007/s40262-016-0434-z. Clin Pharmacokinet. 2017. PMID: 27417226
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical